PopPK Modeling for Optimized Dosing Regimen Design
For modified-release pharmaceutical formulations, PK datasets from multiple dosage variants are integrated and systematically curated to construct a robust PopPK model. Critical covariates that influence systemic pharmacokinetics (body weight, gender, age, etc.) are identified and quantified to refine safe and effective dosing regimens, supplying core modeling data for marketing authorization submissions (NDA/ANDA).
B²O Pharma is an innovative pharmaceutical R&D enterprise focusing on AI-driven clinical pharmacology and quantitative pharmacology, dedicated to advancing model-informed drug development.
Contact Information
Mobile: +86 13564226688
Email: chengs@b2osim.com
WeChat ID: Gd-123998
Address: Room 811, Huayuan World Plaza, No.1958 North Zhongshan Road, Putuo District, Shanghai, P.R.China